Relationship between CD33 expression, splicing polymorphism, and in vitro cytotoxicity of gemtuzumab ozogamicin and the CD33/CD3 BiTE® AMG 330
George S. Laszlo,
Mary E. Beddoe,
Colin D. Godwin,
Olivia M. Bates,
Chelsea J. Gudgeon,
Kimberly H. Harrington,
Roland B. Walter
Affiliations
George S. Laszlo
Clinical Research Division, Fred Hutchinson Cancer Research Center
Mary E. Beddoe
Clinical Research Division, Fred Hutchinson Cancer Research Center
Colin D. Godwin
Hematology/Oncology Fellowship Program
Olivia M. Bates
Clinical Research Division, Fred Hutchinson Cancer Research Center
Chelsea J. Gudgeon
Clinical Research Division, Fred Hutchinson Cancer Research Center
Kimberly H. Harrington
Clinical Research Division, Fred Hutchinson Cancer Research Center
Roland B. Walter
Hematology/Oncology Fellowship Program;Department of Medicine, Division of Hematology;Department of Epidemiology, University of Washington, Seattle, WA, USA